Stock Track | CorMedix Inc. Plummets 5.24% Intraday After Leerink Partners Slashes Target Price

Stock Track01-12

CorMedix Inc. (CRMD) saw its stock plummet by 5.24% during intraday trading on Monday, following a significant target price cut by Leerink Partners.

The investment firm reduced its target price for CorMedix from $21 to $15, signaling reduced confidence in the company's near-term prospects. This adjustment likely triggered a sell-off among investors, leading to the sharp decline in the stock's price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment